SMTL ID : 7d4b.1

Crystal structure of 4-1BB in complex with a VHH

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.14 Å
Oligo State
hetero-1-1-mer
Ligands
1 x NAG- NAG- BMA- MAN- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
3 x CL: CHLORIDE ION(Non-functional Binders)
3 x SO4: SULFATE ION(Non-functional Binders)
2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Zhai, T. et al., Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer. J Immunother Cancer (2021)
Release Date
2021-07-14
Peptides
Tumor necrosis factor receptor superfamily member 9: A
anti-4-1BB VHH: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Tumor necrosis factor receptor superfamily member 9

anti-4-1BB VHH